Paxil Delisting: Will Appellate Case On FDA Patent Listing Role Be Moot?

TorPharm expects an appeals court case on FDA's role in policing patent listings to remain viable despite GlaxoSmithKline's request that three of the Paxil patents at issue in the lawsuit be delisted